Mandate

Vinge has advised Deutsche Börse in connection with its acquisition of Institutional Shareholder Services Inc.

Vinge has advised Deutsche Börse, one of the world’s largest operators of marketplaces for securities trading, in the Swedish part of the acquisition of a majority holding amounting to approximately 80% of Institutional Shareholder Services Inc., a leading provider of ESG data, steering and analysis to investors.

The acquisition, which values Institutional Shareholder Services Inc. to approximately SEK 20 billion, is conditional upon the salient regulatory approvals and customary conditions to closing.

Vinge’s team primarily consisted of Fredrik Wilkens (responsible partner), Henrik Schön (project manager and regulatory issues), Anton Sjökvist (regulatory issues) and Sara Strandberg (employment law).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024